Horse Sarcoid Advanced: ECT and Emerging Treatments

Advanced review of electrochemotherapy (ECT) for equine sarcoids, emerging treatment options, and the evidence base for choosing between available interventions.

Key Facts

Electrochemotherapy (ECT) combines bleomycin or cisplatin chemotherapy with brief electrical pulses that dramatically increase drug uptake in tumor cells
ECT achieves complete response rates of 65-85% for fibroblastic sarcoids in multiple published case series, with recurrence rates of 15-20% — superior to most alternatives
Treatment typically requires 2-3 sessions at 4-6 week intervals under standing sedation — welfare burden is manageable compared to surgical alternatives for large lesions
Topical imiquimod cream (Aldara) has shown effectiveness for superficial sarcoids and is suitable for owner application under veterinary guidance
Surgical excision has high recurrence rates (50-75%) for most sarcoid types without adjunctive treatment — surgery alone is generally inadequate
New immunotherapy approaches including intratumoral cisplatin injection and photodynamic therapy are showing promise in early clinical studies

Welfare Considerations

The availability of ECT as an effective, moderately welfare-positive treatment for equine sarcoids represents a significant advance over the alternatives of surgical excision (high recurrence) or cytotoxic topical treatments (welfare-negative application process). The welfare comparison between treatment options must account for both procedure welfare cost and outcome — a more welfare-costly procedure that achieves lasting resolution may be preferable to a less invasive procedure that fails and requires repeated treatment. ECT requires specialist equipment and expertise but provides the best documented outcome for fibroblastic sarcoids — the most welfare-significant type. Access to ECT specialists is improving as the treatment becomes more widely available in equine oncology practice.

What You Can Do

Seek referral to an equine oncology specialist or ECT practitioner for any fibroblastic or mixed sarcoid requiring treatment
Ask your primary equine veterinarian about ECT availability in your region before committing to surgical excision as the treatment approach
Discuss the recurrence risk of surgical excision for your specific sarcoid type and location — for many cases ECT provides substantially better outcomes
Follow a consistent monitoring protocol after treatment — early detection of recurrence allows retreatment before significant progression
Learn about sarcoid type classification to understand the evidence base for different treatment approaches in your specific situation